| Prev Close | 67.79 |
| Day Low/High | 67.36 / 69.33 |
| 52 Wk Low/High | 52.04 / 76.44 |
CVS Health Corporation (CVS)
67.54
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1308.91B |
| Market Cap | 88.73B |
| P/E Ratio | 11.21 |
| Div & Yield | N.A. (N.A) |
Latest News
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
Home Depot to Investors: We're Going to Be Aggressive
I'm long HD. Despite today's drop, I do not yet see this as a buying opportunity.
What's Still Worth Buying? A Lot
I've got 16 names to consider -- and one that's really a crafty one.
Can These 2 Blue Chips Stocks Still Be Bargains After Just Surging Over 27%?
The short answer? Yes!
CVS Is Aggressive and Optimistic, and I'm Long the Shares
The firm's Q3 earnings easily beat Wall Street's expectations.
Appomattox Moment Needed, Surging Semis, Powell's Plea, Peloton Pelted
Plus, the rising possibility that the Senate may not remain in Republican control should give investors pause.
Real Money Post Industrial Average Rises 21% Year to Date
The average declined in October, but it was less than that hit took by the major indexes.
Decision Time -- for These Stocks, at Least
While the market appears to be enjoying the election results (so far), here's my take on electric vehicles, health care, metals and restaurants.
4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
Indicators Say Traders Aren't Holding Celsius Holdings
Shares of the fitness beverage maker look stuck in a sideways pattern after a big run higher amid what is likely profit taking.
Real Money Post Industrial Average Outperforms Major Indexes in September
The RMPIA rose 13.8% during the quarter, leaving it up just shy of 29% on a year-to-date basis, thanks to performance by CRM, AAPL , NKE and TMO.
Jim Cramer: Better to Mask and Test Than Wait for Vaccine
New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.
Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.
Neither candidate seems to be the enemy of the market -- at least not yet.
A Tale of Two Markets
So, is this a good time, or a bad time to buy stocks? Yes, and yes.
Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
Refuse to Be Gaslighted by Market Pundits
Follow fundamentals and ignore the attempts to gaslight you into not believing your own projections.
Get Your Portfolio Healthy with CVS
CVS has strong fundamentals, a good price, and plenty of room to catch up.
This Dividend Stock Is Just What the Doctor Ordered
CVS is an undervalued health care stock with a solid dividend yield above 3%.
Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon
It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.
Jim Cramer: We Have Underestimated Our Covid-19 Enemy
Why aren't we figuring out how to cure the test bottleneck?
Jim Cramer: Let's Unmask the Anti-Mask Folks as Truly Un-American
Even the president has switched sides on this issue that could help flatten the curve and help get the economy rolling again.
Let's Take Another Look at the Charts and Indicators of CVS Health
If you are long CVS continue to hold.
Jim Cramer: 'Excuse Selling'
Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.
Real Money Post Industrial Average Outperforms, Despite Outbreak
The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.
Is the Fed Going Out of (Yield Curve) Control?
The Federal Reserve posted its June meeting minutes and a report on individual corporate bonds bought so far. Here's my take on both.
I Wouldn't Buy Pfizer Shares on This Pop
I would wait until the next down day, and there will be one.
I've Got the Perfect Prescription for Your Portfolio
Here's how to play CVS Health and avoid most negative investing side effects.
